Shareholders Equity: The sum of preferred and common equity items.
Vir Biotechnology, Inc. (VIR) had Shareholders Equity of $812.76M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$-0.03M |
|
$-125.69M |
|
-- |
|
$-0.03M |
|
$132.26M |
|
$-132.29M |
|
$6.76M |
|
$-125.53M |
|
$-125.53M |
|
$-125.69M |
|
$-125.69M |
|
$-125.69M |
|
$-125.69M |
|
$-132.29M |
|
$-129.09M |
|
147.36M |
|
147.36M |
|
$-0.85 |
|
$-0.85 |
|
| Balance Sheet Financials | |
$522.99M |
|
$53.16M |
|
$502.60M |
|
$1.03B |
|
$73.56M |
|
-- |
|
$139.26M |
|
$212.82M |
|
$812.77M |
|
$788.05M |
|
|
Shareholders Equity |
$812.76M |
161.23M |
|
| Cash Flow Statement Financials | |
$-132.39M |
|
$11.84M |
|
$162.52M |
|
$241.07M |
|
$283.04M |
|
$41.97M |
|
$12.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
456172.50% |
|
456172.50% |
|
-- |
|
432844.80% |
|
433431.10% |
|
$-132.78M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-15.47% |
|
-15.95% |
|
-12.26% |
|
-15.47% |
|
$5.04 |
|
$-0.90 |
|
$-0.90 |
|